A RAPID AND PRECISE DIAGNOSTIC TEST FOR THE DETECTION OF COVID-19 IN 20 MINUTES
Coronavirus Disease 2019 (COVID-19) is an acute respiratory illness caused by infection with the SARS-CoV-2, which was initially reported to WHO in Wuhan, China, on December 31, 2019. The SARS-CoV-2 is from the same family of viruses as Severe Acute Respiratory Syndrome (SARS) and spreads from person to person. Virus-laden droplets from an infected person can be transmitted through the nose, eyes, or mouth of another.
The VitaPCR™ SARS-CoV-2 Gen 2 Assay performed on the VitaPCR™ Instrument is a rapid molecular in vitro diagnostic test utilizing a real-time reverse transcription polymerase chain reaction(rRT-PCR) amplification technology for the qualitative detection of SARS-CoV-2 RNA in nasopharyngeal or nasal swabs from patients with signs and symptoms of respiratory infection.
VitaPCRTM: ACCURATE DIAGNOSTICS, WHENEVER AND WHEREVER YOU NEED IT
Combining a simplified 1 minute hands-on time procedure to ensure seamless integration into practitioners’ workflow, a compact and reliable design that doesn’t require extra equipment like a refrigerator, and a proprietary PCR technology allowing fast and accurate diagnostics, VitaPCR™ allows the detection of SARS-CoV-2 in 20 minutes from sample to results, at the Point-of-Care.
VitaPCR™ empowers practitioners with the right information at the right time, so they can make the right decision and provide the right course of treatment to the patients.
|
For use under Emergency Use Authorization (EUA) only |
GENERAL DIAGNOSTIC PROCEDURE
![]() |
![]() |
INTUITIVE RESULT INTERPRETATION
VitaPCR™ SARS-CoV-2 Gen 2 Assay Specifications | |
---|---|
Catalog No. | PCRAE0118 |
Technology | Real-Time RT-PCR |
Targets | Nucleocapsid Gene |
Quantity | 20 tests/box |
Sample Types | Nasopharyngeal or Nasal Swabs |
Hands-on Time | < 1 min |
Turnaround Time | 20 mins |
Kit Storage | 5 - 25 °C / 41 - 77 °F |
Reference
-
Trigt RV, Neat J, Brouwer JL, Hays A, Westerhof H. Deploying a rapid point of care polymerase chain reaction test for SARS-CoV-2 in a clinical research unit to ensure healthy volunteer safety. Bioanalysis. 2021;10.4155/bio-2021-0079.
-
Musumeci A, Vinci M, L'Episcopo F, et al. Implementation of Sample Pooling Procedure Using a Rapid SARS-CoV-2 Diagnostic Real-Time PCR Test Performed Prior to Hospital Admission of People with Intellectual Disabilities. Int J Environ Res Public Health. 2021;18(17):9317.
-
Fournier PE, Edouard S, Wurtz N, et al. Contagion Management at the Méditerranée Infection University Hospital Institute. J Clin Med. 2021;10(12):2627.
-
Fitoussi, F., Dupont, R., Tonen-Wolyec, S., & Bélec, L. (2021). Performances of the VitaPCR™ SARS-CoV-2 Assay during the second wave of the COVID-19 epidemic in France. Journal of medical virology, 93(7), 4351–4357.
-
Fournier PE, Zandotti C, Ninove L, et al. Contribution of VitaPCR SARS-CoV-2 to the emergency diagnosis of COVID-19. J Clin Virol. 2020;133:104682.
|
|